Carnegie Capital Asset Management, LLC 9 Meters Biopharma, Inc. Transaction History

Carnegie Capital Asset Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$0.26 - $0.64 $2,600 - $6,400	10,000 New	10,000 $3,000
Q2 2022 Jul 13, 2022	SELL	$0.26 - $0.64 $2,600 - $6,400	-10,000 Closed	0 $0
Q3 2021 Oct 08, 2021	BUY	$1.03 - $1.41 $10,300 - $14,100	10,000 New	10,000 $13,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.